47.73
price down icon0.20%   -0.05
 
loading
Schlusskurs vom Vortag:
$47.78
Offen:
$47.64
24-Stunden-Volumen:
117.60K
Relative Volume:
0.07
Marktkapitalisierung:
$120.15B
Einnahmen:
$53.04B
Nettoeinkommen (Verlust:
$4.93B
KGV:
15.04
EPS:
3.1735
Netto-Cashflow:
$15.63B
1W Leistung:
-0.28%
1M Leistung:
-11.13%
6M Leistung:
-2.58%
1J Leistung:
+2.44%
1-Tages-Spanne:
Value
$47.56
$47.76
1-Wochen-Bereich:
Value
$47.45
$48.67
52-Wochen-Spanne:
Value
$45.22
$58.97

Sanofi Adr Stock (SNY) Company Profile

Name
Firmenname
Sanofi Adr
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
87,994
Name
Twitter
@sanofi
Name
Nächster Verdiensttermin
2024-10-25
Name
Neueste SEC-Einreichungen
Name
SNY's Discussions on Twitter

Vergleichen Sie SNY mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
SNY 47.73 120.15B 53.04B 4.93B 15.63B 3.1735
LLY 745.81 693.54B 40.86B 8.37B -2.28B 5.4193
NVO 102.26 465.74B 39.36B 13.79B 9.83B 2.4077
JNJ 153.22 353.35B 87.70B 14.68B 19.03B 13.47
ABBV 167.96 294.70B 55.53B 5.12B 15.62B 3.65
MRK 97.56 248.54B 63.17B 12.15B 14.84B 1.80

Sanofi Adr Stock (SNY) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-07-26 Bestätigt Argus Buy
2024-01-23 Eingeleitet Morgan Stanley Equal-Weight
2024-01-16 Fortgesetzt UBS Buy
2023-12-05 Herabstufung JP Morgan Overweight → Neutral
2023-10-30 Herabstufung Stifel Buy → Hold
2023-09-06 Hochstufung Berenberg Hold → Buy
2023-07-14 Eingeleitet HSBC Securities Buy
2023-04-28 Herabstufung Deutsche Bank Hold → Sell
2023-03-27 Hochstufung Barclays Equal Weight → Overweight
2022-12-13 Fortgesetzt Morgan Stanley Overweight
2022-08-12 Hochstufung Deutsche Bank Sell → Hold
2022-08-09 Herabstufung UBS Buy → Neutral
2022-05-23 Eingeleitet SVB Leerink Outperform
2021-09-27 Hochstufung SVB Leerink Mkt Perform → Outperform
2021-01-15 Eingeleitet Deutsche Bank Sell
2020-09-29 Eingeleitet Berenberg Hold
2020-03-17 Hochstufung Barclays Underweight → Equal Weight
2020-03-11 Hochstufung Goldman Neutral → Buy
2020-02-11 Eingeleitet SVB Leerink Mkt Perform
2020-01-06 Hochstufung JP Morgan Neutral → Overweight
2019-09-23 Hochstufung Guggenheim Neutral → Buy
2019-09-20 Hochstufung Morgan Stanley Equal-Weight → Overweight
2019-09-03 Eingeleitet Bernstein Outperform
2019-08-14 Hochstufung UBS Neutral → Buy
2018-12-11 Hochstufung Jefferies Hold → Buy
2018-11-01 Hochstufung Barclays Underweight → Equal Weight
2018-10-09 Eingeleitet Guggenheim Neutral
2018-09-10 Hochstufung BofA/Merrill Neutral → Buy
2018-08-10 Hochstufung Citigroup Neutral → Buy
2018-03-23 Hochstufung Liberum Hold → Buy
2018-01-23 Herabstufung Barclays Equal Weight → Underweight
2017-12-06 Herabstufung BofA/Merrill Buy → Neutral
2017-12-01 Herabstufung Morgan Stanley Overweight → Underweight
2017-11-15 Hochstufung Barclays Underweight → Equal Weight
2017-08-30 Hochstufung HSBC Securities Reduce → Hold
Alle ansehen

Sanofi Adr Aktie (SNY) Neueste Nachrichten

pulisher
Nov 20, 2024

Weekly Upgrades and Downgrades - InvestorPlace

Nov 20, 2024
pulisher
Nov 15, 2024

FDA To Revisit Regeneron/Sanofi's Dupixent For Rare Skin Disease - Benzinga

Nov 15, 2024
pulisher
Nov 12, 2024

Communiqué de presse - GlobeNewswire Inc.

Nov 12, 2024
pulisher
Nov 06, 2024

T-Cell Lymphoma Pipeline Insight Analysis Report 2024 - GlobeNewswire Inc.

Nov 06, 2024
pulisher
Oct 30, 2024

Sanofi Cancels Consumer Healthcare Business Spin-Off - Forbes

Oct 30, 2024
pulisher
Oct 30, 2024

Here’s Why Mastercard Incorporated (NYSE: MA) Is An Attractive Investment Right Now - Stocks Register

Oct 30, 2024
pulisher
Oct 28, 2024

Sanofi (SNY) Stock Price, News, Quote & History - Yahoo Finance

Oct 28, 2024
pulisher
Oct 28, 2024

16 New 4-Star Stocks - Morningstar

Oct 28, 2024
pulisher
Oct 27, 2024

Sanofi SA (ADR: SNY) Stock Price Could Reach $63: Morningstar Research - TopNews India

Oct 27, 2024
pulisher
Oct 27, 2024

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading - MSN

Oct 27, 2024
pulisher
Oct 25, 2024

Sanofi Eyes Breakout After Pharma Titan Rides Vaccine Sales To Quarterly Beat - Investor's Business Daily

Oct 25, 2024
pulisher
Oct 25, 2024

Biliary Tract Cancer Market Research Report 2024-2030 with Analyst Recommendations - GlobeNewswire Inc.

Oct 25, 2024
pulisher
Oct 24, 2024

Sanofi, HCA, Colgate-Palmolive lead Friday's earnings lineup By Investing.com - Investing.com Australia

Oct 24, 2024
pulisher
Oct 24, 2024

Sanofi, HCA, Colgate-Palmolive lead Friday's earnings lineup - Investing.com

Oct 24, 2024
pulisher
Oct 21, 2024

Sanofi Deal Jitters Imperil Stock’s Big Rebound - MSN

Oct 21, 2024
pulisher
Oct 21, 2024

Sanofi Negotiating Exclusively With CD&R for Opella 50% Stake Sale - Zacks Investment Research

Oct 21, 2024
pulisher
Oct 21, 2024

Proactive news headlines: Ananda, Helix Exploration, Deltic, Light Science Technologies and more - Proactive Investors UK

Oct 21, 2024
pulisher
Oct 21, 2024

French govt set to take stake in Sanofi unit after PE sale - Proactive Investors Australia

Oct 21, 2024
pulisher
Oct 15, 2024

European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading - MSN

Oct 15, 2024
pulisher
Oct 15, 2024

Ophthalmic Disease Therapeutics Market Analysis by Age-related Macular Degeneration, Diabetic Macular Edema, & Other Retinal Disorders - GlobeNewswire Inc.

Oct 15, 2024
pulisher
Oct 14, 2024

10 Best Blue-Chip Stocks to Buy for the Long Term - Morningstar

Oct 14, 2024
pulisher
Oct 10, 2024

Sanofi ADR: A Year of Highs, Lows, and Market Resilience - The InvestChronicle

Oct 10, 2024
pulisher
Oct 09, 2024

Ratios Reveal: Breaking Down Sanofi ADR (SNY)’s Financial Health - The Dwinnex

Oct 09, 2024
pulisher
Oct 09, 2024

EXK (Endeavour Silver Corp.) may reap gains as insiders became active recently - Knox Daily

Oct 09, 2024
pulisher
Oct 09, 2024

Checking in on Clear Channel Outdoor Holdings Inc. (CCO) after recent insiders movement - Knox Daily

Oct 09, 2024
pulisher
Oct 09, 2024

Investing in Sanofi ADR (SNY): What You Must Know - Knox Daily

Oct 09, 2024
pulisher
Oct 09, 2024

Investing in Replimune Group Inc (REPL) Is Getting More Attractive - Knox Daily

Oct 09, 2024
pulisher
Oct 09, 2024

An Analysis of KE Holdings Inc ADR (BEKE)’s Potential Price Growth - Knox Daily

Oct 09, 2024
pulisher
Oct 09, 2024

Europe Pruritus Therapeutics Market Size & Outlook, 2030 - Grand View Research

Oct 09, 2024
pulisher
Oct 08, 2024

OTC Drug and Dietary Supplement Market Opportunities and Strategies to 2033 - GlobeNewswire Inc.

Oct 08, 2024
pulisher
Oct 07, 2024

Precidian to List First ADRhedged Securities in the U.S. on Cboe, Providing Exposure to Individual International Companies with an Embedded Currency Hedge - PR Newswire

Oct 07, 2024

Finanzdaten der Sanofi Adr-Aktie (SNY)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
drug_manufacturers_general BMY
$57.53
price down icon 0.70%
drug_manufacturers_general PFE
$24.84
price down icon 0.38%
$286.05
price down icon 0.09%
drug_manufacturers_general NVS
$103.35
price down icon 0.20%
drug_manufacturers_general MRK
$97.70
price up icon 1.40%
Kapitalisierung:     |  Volumen (24h):